Top Key Companies for Digital Therapeutics for Mental Health Market: Noom, Teladoc Health, Omada Health, WellDoc, Pear Therapeutics, COGNIFlT, Ginger, Propeller Health, 2Morrow, Canary Health, Livongo Health, Proteus Digital Health, Akili Interactive, Big Health, Click Therapeutics, Orexo.
Global Digital Therapeutics for Mental Health Market Size was estimated at USD 436.96 million in 2022 and is projected to reach USD 573.95 million by 2028, exhibiting a CAGR of 4.65% during the forecast period.
Global Digital Therapeutics for Mental Health Market Overview And Scope:
The Global Digital Therapeutics for Mental Health Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Digital Therapeutics for Mental Health utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Digital Therapeutics for Mental Health Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Digital Therapeutics for Mental Health portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Digital Therapeutics for Mental Health market.
Global Digital Therapeutics for Mental Health Market Segmentation
By Type, Digital Therapeutics for Mental Health market has been segmented into:
Treatment Care
Preventive Care
By Application, Digital Therapeutics for Mental Health market has been segmented into:
Pharmaceutical Companies
Hospital & Special Clinic
Patients
Others
Regional Analysis of Digital Therapeutics for Mental Health Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Digital Therapeutics for Mental Health Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Digital Therapeutics for Mental Health market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Digital Therapeutics for Mental Health market.
Top Key Companies Covered in Digital Therapeutics for Mental Health market are:
Noom
Teladoc Health
Omada Health
WellDoc
Pear Therapeutics
COGNIFlT
Ginger
Propeller Health
2Morrow
Canary Health
Livongo Health
Proteus Digital Health
Akili Interactive
Big Health
Click Therapeutics
Orexo
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Digital Therapeutics for Mental Health Market by Type
5.1 Digital Therapeutics for Mental Health Market Overview Snapshot and Growth Engine
5.2 Digital Therapeutics for Mental Health Market Overview
5.3 Treatment Care
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Treatment Care: Geographic Segmentation
5.4 Preventive Care
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Preventive Care: Geographic Segmentation
Chapter 6: Digital Therapeutics for Mental Health Market by Application
6.1 Digital Therapeutics for Mental Health Market Overview Snapshot and Growth Engine
6.2 Digital Therapeutics for Mental Health Market Overview
6.3 Pharmaceutical Companies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmaceutical Companies: Geographic Segmentation
6.4 Hospital & Special Clinic
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Hospital & Special Clinic: Geographic Segmentation
6.5 Patients
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Patients: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Digital Therapeutics for Mental Health Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Digital Therapeutics for Mental Health Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Digital Therapeutics for Mental Health Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NOOM
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 TELADOC HEALTH
7.4 OMADA HEALTH
7.5 WELLDOC
7.6 PEAR THERAPEUTICS
7.7 COGNIFLT
7.8 GINGER
7.9 PROPELLER HEALTH
7.10 2MORROW
7.11 CANARY HEALTH
7.12 LIVONGO HEALTH
7.13 PROTEUS DIGITAL HEALTH
7.14 AKILI INTERACTIVE
7.15 BIG HEALTH
7.16 CLICK THERAPEUTICS
7.17 OREXO
Chapter 8: Global Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Treatment Care
8.2.2 Preventive Care
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmaceutical Companies
8.3.2 Hospital & Special Clinic
8.3.3 Patients
8.3.4 Others
Chapter 9: North America Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Treatment Care
9.4.2 Preventive Care
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmaceutical Companies
9.5.2 Hospital & Special Clinic
9.5.3 Patients
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Treatment Care
10.4.2 Preventive Care
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmaceutical Companies
10.5.2 Hospital & Special Clinic
10.5.3 Patients
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Treatment Care
11.4.2 Preventive Care
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmaceutical Companies
11.5.2 Hospital & Special Clinic
11.5.3 Patients
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Treatment Care
12.4.2 Preventive Care
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmaceutical Companies
12.5.2 Hospital & Special Clinic
12.5.3 Patients
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Treatment Care
13.4.2 Preventive Care
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmaceutical Companies
13.5.2 Hospital & Special Clinic
13.5.3 Patients
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Digital Therapeutics for Mental Health Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Treatment Care
14.4.2 Preventive Care
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmaceutical Companies
14.5.2 Hospital & Special Clinic
14.5.3 Patients
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Digital Therapeutics for Mental Health Scope:
|
Report Data
|
Digital Therapeutics for Mental Health Market
|
|
Digital Therapeutics for Mental Health Market Size in 2025
|
USD XX million
|
|
Digital Therapeutics for Mental Health CAGR 2025 - 2032
|
XX%
|
|
Digital Therapeutics for Mental Health Base Year
|
2024
|
|
Digital Therapeutics for Mental Health Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Noom, Teladoc Health, Omada Health, WellDoc, Pear Therapeutics, COGNIFlT, Ginger, Propeller Health, 2Morrow, Canary Health, Livongo Health, Proteus Digital Health, Akili Interactive, Big Health, Click Therapeutics, Orexo.
|
|
Key Segments
|
By Type
Treatment Care
Preventive Care
By Applications
Pharmaceutical Companies
Hospital & Special Clinic
Patients
Others
|
